Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of bicalutamide
50 mg tablet (test) versus Casodex (reference), administered as 1 x 50 mg tablet under
fasting conditions